SHOrt-term Glycemic Control for Reducing Post-SURGical Complications

Launched by MANSOURA UNIVERSITY · Mar 21, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "SHOrt-term Glycemic Control for Reducing Post-SURGical Complications," aims to understand how managing blood sugar levels in the short term before major abdominal surgery can affect recovery and complications after the surgery. Researchers have noticed that patients with diabetes often face more challenges after surgery, especially if their blood sugar is not well-controlled. However, there hasn't been a study to see if improving blood sugar just before surgery can help reduce these risks and prevent delays in scheduling surgeries.

To be eligible for this trial, participants must be adults aged 18 and older with diabetes who are scheduled for major abdominal surgery that will take more than two hours. They should have a specific blood sugar measure called HbA1c that is 7.5% or higher. Unfortunately, those under 18, those needing emergency surgery, pregnant individuals, or those who can safely wait for their surgery until their blood sugar is controlled will not be included. If you participate, you can expect to receive support to manage your blood sugar levels in the lead-up to your surgery, and the results could help improve care for future patients like you.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all adult diabetic patients (≥18 years) of either sex scheduled for major abdominal surgery (estimated operative time is \> 2 hours) with Hb A1c ≥7.5% (58 mmol/mol).
• Exclusion Criteria:
• • Patients \< 18 years
• • Emergency Surgery
• • Elective surgery that can be postponed safely till glycemic control
• • Hb A1c \< 7.5%
• • Pregnant patients
• • Patient Refusal